Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Penehyclidine for PONV in Bimaxillary Surgery
NCT04454866Completed
- Sponsor
- Peking University First Hospital
- Start
- Jul 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of penehyclidine in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Peking University First Hospital. Primary endpoint: Incidence of nausea and vomiting within 72 hours after bimaxillary surgery. Started Jul 2020; status: completed.
02
Drugs
penehyclidine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT04454866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04454866.